Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500 Futures
(0.28%) 5 310.25 points
Dow Jones Futures
(0.31%) 38 913 points
Nasdaq Futures
(0.32%) 18 651 points
Oil
(-0.06%) $76.94
Gas
(4.48%) $2.70
Gold
(-0.18%) $2 341.50
Silver
(-0.16%) $30.39
Platinum
(0.49%) $1 047.10
USD/EUR
(0.02%) $0.921
USD/NOK
(0.00%) $10.49
USD/GBP
(-0.03%) $0.785
USD/RUB
(-0.46%) $90.02

Realtime updates for Fusion Antibodies PLC [FAB.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-06-07)

Expected move: +/- 7.35%

Last Updated31 May 2024 @ 11:29
25% discount on Stockinvest.us - Use code: Podcast

-1.32% £ 3.75

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 11:29):

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally...

Stats
Today's Volume 474 407
Average Volume 1.11M
Market Cap 3.58M
EPS £0 ( 2023-12-07 )
Next earnings date ( £0 ) 2024-06-07
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -0.420
ATR14 £0.0460 (1.23%)

Fusion Antibodies PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fusion Antibodies PLC Financials

Annual 2022
Revenue: £2.90M
Gross Profit: £202 000 (6.96 %)
EPS: £-0.0998
FY 2022
Revenue: £2.90M
Gross Profit: £202 000 (6.96 %)
EPS: £-0.0998
FY 2022
Revenue: £4.80M
Gross Profit: £2.47M (51.39 %)
EPS: £-0.0463
FY 2021
Revenue: £4.17M
Gross Profit: £2.02M (48.60 %)
EPS: £-0.131

Financial Reports:

No articles found.

Fusion Antibodies PLC Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Fusion Antibodies PLC

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 3.8023838996887 seconds
Number of API calls: 2
Number of DB calls: 8